It is estimated that about 500 million cases of malaria occur annually (19) , with between one and two million deaths being caused by Plasmodium falciparum (2) . It is believed that 75 to 80% of the world's population relies on traditional remedies to treat the disease (10) ; plants thus represent the only antimalarial therapy for a large proportion of the world's population. The reputation of plants used as febrifuges and in the treatment of malaria is increasingly being investigated, since plants may yield novel antimalarial agents. As part of a continuing investigation of plants used in traditional medicine (4, (13) (14) (15) (16) 24) , we have screened for in vitro antimalarial activity 12 plants which have reputations as either antimalarial agents or febrifuges in Sierra Leone (11, 15) . The most active extract was that from the wood of a menispermaceous climber, Tnclisia patens, a plant known to contain bisbenzylisoquinoline (BBIQ) alkaloids (3, 20) . Screening of the related species Tnclisia dictyophylla revealed that this plant also has potent antiplasmodial properties in vitro. Constituent alkaloids, such as phaeanthine, pycnamine, aromoline, isotetrandrine, obamegine, and gilletine, from both species showed antiplasmodial activity in vitro (11, 15, 16) , and it is thought that these alkaloids are responsible, at least in part, for the antimalarial activity of these two menispermaceous species. Independent investigations into the antimalarial activity of Tiliacora tnandra (Menispermaceae) from Thailand have shown that the BBIQ alkaloids tiliacorine, tiliacorinine, and nortiliacorinine A are the active principles (17) . The antimalarial activity of eight BBIQ alkaloids is the subject of a patent (22) .
Plants containing BBIQ alkaloids are also used in tradi-tional medicine for the treatment of a number of diseases, including amoebic dysentery, leishmaniasis, bacterial infections, and cancer (6, (8) (9) (10) 12) . The BBIQ alkaloid tetrandrine has been used clinically in China for the treatment of amoebic dysentery, lung cancer, and leukemia (9) . To further our understanding of some of these activities, we decided to investigate the in vitro action of 24 BBIQ alkaloids against P. falciparum, Entamoeba histolytica, and KB cells (carcinoma of the human nasopharynx). The aims of this investigation were to ascertain some of the structural requirements for activity, to learn whether these alkaloids have any selectivity of action, and to provide further insight into the active principles of plants which are used in traditional medicine.
MATERUILS AND METHODS
BBIQ samples were available in one of our laboratories (that of P.L.S.). Chloroquine diphosphate, emetine dihydrochloride, and podophyllotoxin were obtained from Sigma, and metronidazole was obtained from May & Baker. The methods used for the in vitro screening of the alkaloids for antiplasmodial, antiamoebic, and cytotoxic activities have been described in detail elsewhere (1, 13, 14, 24) and will only be outlined here.
In vitro microtest for detecting antiplasmodial activity. The screening procedure for antiplasmodial activity compared the inhibition of the incorporation of tritiated hypoxanthine into drug-treated P. falciparum-infected erythrocytes, untreated infected erythrocytes, and uninfected controls. A multidrug-resistant strain of P. falciparum (K1) was maintained according to the methods of Trager and Jensen (21) and Fairlamb et al. (5) (4) a (2) 8.04 (4) 4.67 (3) 5.95 (4) - (2) 6.83 (4) 4.42 (4) 0.82 (4) 6.54 (4) 10.8 (4) - (2) - (2) - (2) 0.86 (4) - (2) 3.47 (4) (1) and, like the antiamoebic activity screening procedure, used eosin as a stain for cellular protein and optical density as a measure of cell number. The KB cell line originated from a nasopharyngeal carcinoma and was maintained for this study in Eagle's modified minimum essential medium with Earle's salts and sodium bicarbonate. The medium was further supplemented with bovine serum, glutamine, and nonessential amino acids. Alkaloids were dissolved or micronized in ethanol (the maximum ethanol concentration was 2.5%, previously determined to have no effect on cell growth) and tested in a 96-well microtiter plate at 12 twofold dilutions, beginning at 125 or 250 ,ug/ml. After 48 h of incubation at 37°C, the medium was removed and eosin was used to assess cell growth as described for the antiamoebic activity screening procedure. IC50s were also derived as described above.
Podophyllotoxin was tested as a control.
RESULTS
The in vitro IC50s of the 24 (18) . The alkaloids investigated in the present work are representative of nine of the known structural types, namely, types IV, VI, VII, VIII, XVIII, XX, XXIII, XXIV, and XXVI (Fig. 1) . Alkaloids within each group differ from one another by their stereochemistry at C-1 and C-l' and/or their substituents and nitrogen functionalities (Fig. 1) .
The results shown in Table 1 (Table 1 ). The IC50s determined by other workers (22) for phaeanthine, pycnamine, isotetrandrine, berbamine, obamegine, and tetrandrine against chloroquine-resistant P. falciparum (W2 strain) are in good agreement with those obtained by us against the Ki strain (Table 1) . We reported previously that phaeanthine (8) is twice as potent against chloroquine-resistant P. falciparum (K1) in vitro as against a chloroquine-susceptible clone (T9-96) (4).
In assessing structure-activity relationships, it can be seen that the 19 BBIQ alkaloids with in vitro antimalarial activities represented by IC50s of less than 10 ,uM (Table 1) have a range of different structures (Fig. 1) . Dimers of the head-to-head and head-to-tail types, e.g., phaeanthine and insularine, are active. The other bridges between the monomeric units may be two or three in number (e.g., tetrandrine and isotrilobine) and may be attached at several different positions on the monomers. It is not necessary for activity that there be an ether linkage between the two monomeric units; e.g., funiferine contains a direct carbon-carbon linkage. The status of the nitrogen atoms is fundamental to antiplasmodial activity, as evidenced by trigilletimine, with an aromatic N-2', being 20-fold less active than isotrilobine, which is the corresponding D ring-saturated, N-2'-methylated analog. Quaternization of N-2' results in the loss of antiplasmodial activity, as indicated by a comparison of tetrandrine methiodide and tetrandrine (Table 1) , and has also been observed to reduce the cytotoxicity of BBIQ alkaloids for HeLa cells (8) . Daphnoline and its N-2'-methylated analog aromoline have IC50s of similar magnitudes, indicating that there is little difference in activity between secondary amine and tertiary N-methyl functions in ring D.
The substituents present in each monomeric half of the molecule may influence antiplasmodial activity. A comparison of phenols and their corresponding methyl ethers indicates that a phenolic hydroxyl may result in less activity; tiliageine is 10 times less active than funiferine, and cocsuline is 40 times less active than isotrilobine (Table 1 ). In contrast, some phenolic substituents result in an increase in activity in comparison with their corresponding methyl ethers, as exemplified by aromoline, which is twice as active as homoaromoline. A comparison of the antiplasmodial activities of aromoline and oxyacanthine, phaeanthine and pycnamine, and tetrandrine and fangchinoline (Table 1) shows that for these pairs of alkaloids, there is little difference in activity between alkaloids possessing particular phenolic substituents and those possessing their corresponding methyl ethers.
Antiplasmodial activity was observed for alkaloids possessing R,R, S,S, R,S, and S,R configurations at C-1 and C-i'. A direct comparison of three alkaloids with identical ether linkages and substituents and differing only at C-1 and C-i' could be made for phaeanthine (R,R), tetrandrine (S,S), and isotetrandrine (R,S), which had IC50s of 1.46, 0.57, and 0.16 ,uM, respectively. There were, however, no significant differences between the activities of phaeanthine and tetrandrine or tetrandrine and isotetrandrine, albeit isotetrandrine was significantly more active than phaeanthine.
None of the 24 alkaloids tested showed significant cytotoxic activity against KB cells, the most active being berbamine, with an IC50 of 17.8 ,uM (Table 1 ). In assessing selectivity of action against P. falciparum versus mammalian cells, we reported previously that the ratio of IC50s in vitro for chloroquine diphosphate is 347 (IC50 for KB cells/IC50 for P. falciparum KI) (1) . In the present investigation, the least cytotoxic alkaloid, thalisopidine, had a cytotoxic activity/ antiplasmodial activity ratio of 455, which was more favorable than that of the more cytotoxic berbamine, which had a corresponding ratio of 39.5. These ratios, which are indicators of selectivity, should be regarded with some caution. The IC50s of the BBIQ alkaloids given in Table 1 tute IC50s of tetrandrine, isotetrandrine, fangchinoline, berbamine, and obamegine were between 0.1 and 8 ,uM (7) (see Table 1 for a comparison).
The most active BBIQ alkaloids against E. histolytica in vitro were aromoline, isotrilobine, and insularine, which had IC5Os in the range of 5 to 11 ,uM ( Table 1 ). The IC50s of the control antiamoebic drugs emetine hydrochloride and metronidazole were 2.2 and 1.87 p.M, respectively ( Table 1 ). The in vitro activity of the BBIQ alkaloids tested was markedly lower against E. histolytica than against P. falciparum, indicating that these alkaloids show some selectivity in antiprotozoal action. The results given in Table 1 for the activities of BBIQ alkaloids against P. falciparum, E. histolytica, and KB cells in vitro provide some justification for the use of menispermaceous plants in traditional medicine as treatments for malaria and amoebic dysentery. Other factors besides direct chemotherapeutic activity may be involved, and it has been reported that some BBIQ alkaloids have immunostimulant activity (23) . The most pronounced activity observed in the present investigation was against P. falciparum. Some of the BBIQ alkaloids have greater activity against chloroquine-resistant strains of P. falciparum than against chloroquine-susceptible strains and may be of use in combination with chloroquine in preventing resistance (4, 22, 25) . Tetrandrine reportedly reverses the resistance of P. falciparum to chloroquine and has a long-acting synergistic effect on the antimalarial action of artemisinin (22) . BBIQ alkaloids merit further investigation as potential novel antimalarial drugs. 
